Modulation of immunity by tryptophan microbial metabolites DOI Creative Commons
Siying Li

Frontiers in Nutrition, Journal Year: 2023, Volume and Issue: 10

Published: June 21, 2023

Tryptophan (Trp) is an essential amino acid that can be metabolized via endogenous and exogenous pathways, including the Kynurenine Pathway, 5-Hydroxyindole Pathway (also Serotonin pathway), Microbial pathway. Of these, Trp metabolic pathways in gut have recently been extensively studied for their production of bioactive molecules. The microbiota plays important role host metabolism immunity, microbial metabolites influence development progression various diseases, inflammatory, cardiovascular neurological cancer, by mediating body’s immunity. This review briefly outlines crosstalk between microorganisms body, starting from three Trp. mechanisms which act on organism immunity are summarized, potential implications disease prevention treatment highlighted.

Language: Английский

Targeting ROS in cancer: rationale and strategies DOI
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham

et al.

Nature Reviews Drug Discovery, Journal Year: 2024, Volume and Issue: 23(8), P. 583 - 606

Published: July 9, 2024

Language: Английский

Citations

120

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy DOI
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy

et al.

Nature Reviews Clinical Oncology, Journal Year: 2023, Volume and Issue: 20(9), P. 583 - 603

Published: June 26, 2023

Language: Английский

Citations

73

Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding DOI Creative Commons
Gang Wang, Yuxin Fan, Guolong Zhang

et al.

Microbiome, Journal Year: 2024, Volume and Issue: 12(1)

Published: March 19, 2024

Abstract Background The host–microbiota interaction plays a crucial role in maintaining homeostasis and disease susceptibility, microbial tryptophan metabolites are potent modulators of host physiology. However, whether how these mediate interactions, particularly terms inter-microbial communication, remains unclear. Results Here, we have demonstrated that indole-3-lactic acid (ILA) is key molecule produced by Lactobacillus protecting against intestinal inflammation correcting dysbiosis. Specifically, metabolizes into ILA, thereby augmenting the expression bacterial enzymes implicated metabolism, leading to synthesis other indole derivatives including indole-3-propionic (IPA) indole-3-acetic (IAA). Notably, IPA, IAA possess ability mitigate modulate gut microbiota both DSS-induced IL-10 −/− spontaneous colitis models. ILA increases abundance tryptophan-metabolizing bacteria (e.g., Clostridium ), as well mRNA acyl-CoA dehydrogenase indolelactate vivo vitro, resulting an augmented production IPA IAA. Furthermore, mutant strain fails protect producing derivatives. ILA-mediated cross-feeding was microbiota-dependent specifically enhanced under conditions dysbiosis induced Citrobacter rodentium or DSS, but not disruption with antibiotics. Conclusion Taken together, highlight mechanisms which microbiome-host crosstalk cooperatively control homoeostasis through microbiota-derived indoles mediating communication. These findings may contribute development targeted “postbiotic” potential interventions for treatment prevention dysbiosis-driven diseases.

Language: Английский

Citations

68

Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition DOI
Weiwei Cui, Meng Guo, Dong Liu

et al.

Nature Cell Biology, Journal Year: 2024, Volume and Issue: 26(1), P. 124 - 137

Published: Jan. 1, 2024

Language: Английский

Citations

66

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential DOI Creative Commons

Yu-Ling Xiao,

Yue Gong,

Ying-Jia Qi

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: March 11, 2024

Abstract Diet, serving as a vital source of nutrients, exerts profound influence on human health and disease progression. Recently, dietary interventions have emerged promising adjunctive treatment strategies not only for cancer but also neurodegenerative diseases, autoimmune cardiovascular metabolic disorders. These demonstrated substantial potential in modulating metabolism, trajectory, therapeutic responses. Metabolic reprogramming is hallmark malignant progression, deeper understanding this phenomenon tumors its effects immune regulation significant challenge that impedes eradication. Dietary intake, key environmental factor, can tumor metabolism. Emerging evidence indicates might affect the nutrient availability tumors, thereby increasing efficacy treatments. However, intricate interplay between pathogenesis other diseases complex. Despite encouraging results, mechanisms underlying diet-based remain largely unexplored, often resulting underutilization management. In review, we aim to illuminate various interventions, including calorie restriction, fasting-mimicking diet, ketogenic protein restriction high-salt high-fat high-fiber aforementioned diseases. We explore multifaceted impacts these encompassing their immunomodulatory effects, biological impacts, molecular mechanisms. This review offers valuable insights into application therapies

Language: Английский

Citations

65

Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors DOI
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer

et al.

Nature Reviews Clinical Oncology, Journal Year: 2023, Volume and Issue: 20(10), P. 697 - 715

Published: July 24, 2023

Language: Английский

Citations

54

Utilization of the microbiome in personalized medicine DOI
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen

et al.

Nature Reviews Microbiology, Journal Year: 2023, Volume and Issue: 22(5), P. 291 - 308

Published: Dec. 18, 2023

Language: Английский

Citations

50

Role of the microbiota in response to and recovery from cancer therapy DOI
Stephen J. Blake, Yochai Wolf, Ben Boursi

et al.

Nature reviews. Immunology, Journal Year: 2023, Volume and Issue: 24(5), P. 308 - 325

Published: Nov. 6, 2023

Language: Английский

Citations

46

Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota DOI Creative Commons
Anurag Kumar Sinha, Martin Frederik Laursen, Julius Emil Brinck

et al.

Nature Microbiology, Journal Year: 2024, Volume and Issue: 9(8), P. 1964 - 1978

Published: June 25, 2024

Tryptophan is catabolized by gut microorganisms resulting in a wide range of metabolites implicated both beneficial and adverse host effects. How microbial tryptophan metabolism directed towards indole, associated with chronic kidney disease, or protective indolelactic acid (ILA) indolepropionic (IPA) unclear. Here we used vitro culturing animal experiments to assess competition for the controlled three-species defined community complex undefined human faecal communities. The generation specific tryptophan-derived was not predominantly determined abundance tryptophan-metabolizing bacteria, but rather substrate-dependent regulation metabolic pathways. Indole-producing Escherichia coli ILA- IPA-producing Clostridium sporogenes competed within vivo. Importantly, fibre-degrading Bacteroides thetaiotaomicron affected this cross-feeding monosaccharides E. coli. This inhibited indole production through catabolite repression, thus making more available C. sporogenes, increased ILA IPA production. fibre-dependent reduction confirmed using cultures faecal-microbiota-transplanted gnotobiotic mice. Our findings explain why consumption fermentable fibres suppresses promotes other health benefits.

Language: Английский

Citations

40

Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation DOI Creative Commons
Mohammad Arifuzzaman,

Nicholas Collins,

Chun‐Jun Guo

et al.

Immunity, Journal Year: 2024, Volume and Issue: 57(1), P. 14 - 27

Published: Jan. 1, 2024

Language: Английский

Citations

38